Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (FCRX) Total Non-Current Liabilities (2021 - 2025)

Historic Total Non-Current Liabilities for Crescent Capital BDC (FCRX) over the last 5 years, with Q3 2025 value amounting to $911.3 million.

  • Crescent Capital BDC's Total Non-Current Liabilities rose 168.69% to $911.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $911.3 million, marking a year-over-year increase of 168.69%. This contributed to the annual value of $884.7 million for FY2023, which is 2818.41% up from last year.
  • Per Crescent Capital BDC's latest filing, its Total Non-Current Liabilities stood at $911.3 million for Q3 2025, which was up 168.69% from $927.1 million recorded in Q2 2025.
  • Over the past 5 years, Crescent Capital BDC's Total Non-Current Liabilities peaked at $939.1 million during Q1 2025, and registered a low of $664.9 million during Q4 2021.
  • In the last 5 years, Crescent Capital BDC's Total Non-Current Liabilities had a median value of $896.2 million in 2024 and averaged $855.7 million.
  • As far as peak fluctuations go, Crescent Capital BDC's Total Non-Current Liabilities soared by 2818.41% in 2023, and later plummeted by 481.12% in 2024.
  • Over the past 5 years, Crescent Capital BDC's Total Non-Current Liabilities (Quarter) stood at $664.9 million in 2021, then rose by 3.8% to $690.2 million in 2022, then grew by 28.18% to $884.7 million in 2023, then grew by 1.3% to $896.2 million in 2024, then grew by 1.69% to $911.3 million in 2025.
  • Its last three reported values are $911.3 million in Q3 2025, $927.1 million for Q2 2025, and $939.1 million during Q1 2025.